In this episode, Joe interviews founder and CEO of MindMed, JR Rahn. They discuss decriminalization, the DEA, ADHD, Xanax, and MindMed's goals: developing a trip-neutralizing drug and studying microdosing LSD for adult ADHD.
www.psychedelicstoday.com 
